Archive for the ‘Latest News’

CGRP Update

7th November 2018

The U.S. Food and Drug Administration (FDA) has approved the  fremanezumab-vfrm injection for the preventive treatment of migraine in adults. This is the second anti-CGRP drug to receive approval from the FDA.  The FDA previously approved the Novartis anti-CGRP monthly injection, containing the human monoclonal antibody Erenumab, and this was granted a marketing license in Ireland earlier this year.The Fremanezumab-vfrm... [read more]


Pharmacists! Order a Pharmacy Pack Today

17th September 2018

Free Migraine Pharmacy Packs The Migraine Association of Ireland with the support of Novartis has produced free information packs including posters and information leaflets which are now available to pharmacists. MAI is actively encouraging patients to seek the expert advice of their local pharmacist to better manage their migraine and headache symptoms. We are also highlighting the services and support provided by The Migraine Association... [read more]


Migraine Nurse Phone Line

Migraine
15th August 2018

Phone access to the Migraine Nurse is now only through the MAI Information and Support Line. If you need to contact her please contact us here on 1850 200 378 or email us at info@migraine.ie and we can help put you in... [read more]


CGRP Update!! All your questions answered.

1st August 2018

CGRP Update Following member’s queries and questions around the introduction of this new drug and in response to the large volume of online comments and questions, (read our original press release here) The Migraine Association sought clarification on a number of issues with Novartis who have confirmed the following: Erenumab is the first and only treatment specifically designed for migraine prevention to be approved in the... [read more]


Migraine Information for non-English Speakers

19th June 2018

Migraine is a disorder that affects all levels of society, gender, age, socio-economic status and nationality. Ireland has grown into a wonderfully diverse country with people from all over the world living, working, bringing their culture here, and unfortunately suffering from migraine too! It can be hard for non- English speakers to access relevant health information in Ireland and in recognition of that information gap, we have translated... [read more]


Archive for the ‘Latest News’

CGRP Update

7th November 2018

The U.S. Food and Drug Administration (FDA) has approved the  fremanezumab-vfrm injection for the preventive treatment of migraine in adults. This is the second anti-CGRP drug to receive approval from the FDA.  The FDA previously approved the Novartis anti-CGRP monthly injection, containing the human monoclonal antibody Erenumab, and this was granted a marketing license in Ireland earlier this year.The Fremanezumab-vfrm... [read more]


Pharmacists! Order a Pharmacy Pack Today

17th September 2018

Free Migraine Pharmacy Packs The Migraine Association of Ireland with the support of Novartis has produced free information packs including posters and information leaflets which are now available to pharmacists. MAI is actively encouraging patients to seek the expert advice of their local pharmacist to better manage their migraine and headache symptoms. We are also highlighting the services and support provided by The Migraine Association... [read more]


Migraine Nurse Phone Line

Migraine
15th August 2018

Phone access to the Migraine Nurse is now only through the MAI Information and Support Line. If you need to contact her please contact us here on 1850 200 378 or email us at info@migraine.ie and we can help put you in... [read more]


CGRP Update!! All your questions answered.

1st August 2018

CGRP Update Following member’s queries and questions around the introduction of this new drug and in response to the large volume of online comments and questions, (read our original press release here) The Migraine Association sought clarification on a number of issues with Novartis who have confirmed the following: Erenumab is the first and only treatment specifically designed for migraine prevention to be approved in the... [read more]


Migraine Information for non-English Speakers

19th June 2018

Migraine is a disorder that affects all levels of society, gender, age, socio-economic status and nationality. Ireland has grown into a wonderfully diverse country with people from all over the world living, working, bringing their culture here, and unfortunately suffering from migraine too! It can be hard for non- English speakers to access relevant health information in Ireland and in recognition of that information gap, we have translated... [read more]